Efficacy of Tocilizumab in Severely Ill COVID-19 Patients With Rapid Respiratory Deterioration: A Single Center Experience During the Third Pandemic Wave in Greece.

Vasiliki Rapti,Maria-Effrosyni Livanou,Anastasios Kollias,Tilemachos Koutouratsas, Orestis Savranakis,Vissaria Sakka,Thomas Nitsotolis,Eleni Kakalou,Kalomoira Athanasiou,Konstantinos N Syrigos,Garyfallia Poulakou

In vivo (Athens, Greece)（2023）

引用 0|浏览14

暂无评分

摘要

Our single-center real-life experience is in line with recently published research, revealing no benefit from TCZ routine use in severely or critically ill patients with COVID-19.

查看译文

关键词

COVID-19,Delta variant,IL-6R blockade,SARS-CoV-2,efficacy,intubation,mortality,tocilizumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要